Cannabis Is the Most Microdosed Psychoactive Substance
via HealthDayTHURSDAY, May 14, 2026 -- A considerable number of U.S. adults report microdosing psychoactive substances in their lifetime, according to a study published online May 3 in the American Journal of Preventive Medicine.
Kevin H. Yang, M.D., from the University of California San Diego School of Medicine in La Jolla, and colleagues used data from 1,525 participants in the Characterizing the Epidemiology of Cannabidiol Use Survey to describe microdosing prevalence, frequency, and reasons.
The researchers found that cannabis was the most commonly microdosed substance (9.4 percent; 24.1 million adults), followed by psilocybin (5.3 percent; 13.7 million adults), LSD (4.8 percent; 12.4 million adults), and 3,4-Methylenedioxymethamphetamine (MDMA; 2.2 percent; 5.7 million adults). Cannabis was mostly microdosed for medical purposes (41.2 percent; e.g., "to manage pain"), while psilocybin (66.6 percent), LSD (59.2 percent), and MDMA (86.0 percent) were more commonly microdosed for recreational purposes. Lifetime microdose use, across all substances, was more prevalent among respondents reporting poorer mental health and among those residing in jurisdictions permitting recreational cannabis use and decriminalized psychedelic possession.
"Most people are microdosing for recreational purposes," senior author Eric Leas, Ph.D., also from the University of California San Diego, said in a statement. "That suggests that many people could think about the concept of 'microdosing' more as a way of lowering dosage. They may just want to take less, so they don’t want to get as high."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-15 02:41
Read more
- Supreme Court Puts Brakes on Abortion Pill Restrictions
- Clinical Trial Suggests Two Simple Ways To Fight Chemo-Related Brain Fog
- Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
- Patients Wait About 50 Days on Average for First Visit to Neurologist
- Glucagon-Like Peptide-1 Receptor Agonists May Be Treatment for Alcohol Use Disorder
- EHRA: Risk for Heart Failure Common for Individuals With Screening-Detected A-Fib
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions